Case Study: Ayurvedic Treatment Of Dyslipidemia Coexisting With Type 2 Diabetes Mellitus

Authors

  • Acharya Manish Director, Meditation Guru, Jeena Sikho Lifecare Limited, India Author
  • Gitika Chaudhary Senior Consultant, General Surgeon, BAMS, PGDIP, PGDGS, MS (Ayurveda), Jeena Sikho Lifecare Limited, India Author
  • Richa Senior Research officer, BAMS, PGDIP, CICR, CAIM, CMW, Jeena Sikho Lifecare Limited, India Author
  • Ashish Rao Consultant, BAMS, Jeena Sikho Lifecare Limited Clinic, Bhagalpur, Bihar, India Author
  • Tanu Rani Research Associate, BAMS, Jeena Sikho Lifecare Limited, India Author

DOI:

https://doi.org/10.48165/IRJAY.2025.80609

Keywords:

Ayurvedic, Cholesterol, Dyslipidemia, Medoroga, Madhumeha, Type 2 Diabetes mellitus

Abstract

Dyslipidemia, characterized by abnormal lipid levels including elevated LDL cholesterol, low HDL cholesterol, and increased triglycerides, is a major risk factor for atherosclerotic cardiovascular disease and is frequently associated with type 2 diabetes mellitus (T2DM). Its multifactorial etiology involves genetic, dietary, and lifestyle influences, and effective management requires early detection and comprehensive intervention. Ayurveda conceptualizes dyslipidemia with T2DM under Medoroga and Madhumeha, attributing the condition to dosha imbalances, especially involving Kapha and Meda Dhatu, and impaired metabolic fire (Agni). Ayurvedic treatments combine purificatory (Shodhana) and palliative (Shamana) therapies, supported by lifestyle and dietary regulation to restore metabolic harmony. This case study reports on a 35-year-old male patient diagnosed with dyslipidemia and T2DM, treated at Jeena Sikho Lifecare Limited Clinic, Bhagalpur, India. Initial complaints included abdominal heaviness and gastritis. Following Ayurvedic intervention, the patient exhibited significant symptomatic relief alongside marked improvements in laboratory parameters. Over a two-month period, total cholesterol, triglycerides and LDL cholesterol were reduced, and HbA1c improved from 8.10% to 5.80%. HDL levels remained borderline but stable, while other lipid fractions such as VLDL and non-HDL cholesterol showed favorable reductions. The integrative Ayurvedic approach targeting dosha balance and metabolic correction effectively improved lipid profiles and glycemic control, contributing to symptom relief and stabilized vital parameters. These promising results highlight the potential of Ayurveda in managing dyslipidemia with T2DM, however, larger-scale clinical trials are necessary to validate these findings and develop standardized treatment protocols.

Downloads

Download data is not yet available.

References

Du Z, Qin Y. Dyslipidemia and cardiovascular disease: current knowledge, existing challenges, and new opportunities for management strategies. J Clin Med. 2023 Jan 3;12(1):363. doi:10.3390/jcm12010363. PMID: 36615163; PMCID: PMC9820834.

Pappan N, Awosika AO, Rehman A. Dyslipidemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. Updated 2024 Mar 4. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560891/

Bezerra C. Dyslipidemia: what it is, how to identify, causes and treatment. Braz J Implantol Health Sci. 2023 Jan 29;5(1):66–72.

Chou R, Dana T, Blazina I, et al. Screening for dyslipidemia in younger adults: a systematic review to update the 2008 U.S. Preventive Services Task Force recommendation. Evidence Syntheses. 2016 Nov;(138). Rockville (MD): Agency for Healthcare Research and Quality (US). Available from: https://www.ncbi.nlm.nih.gov/books/NBK396239/

Sawhney JP, Ramakrishnan S, Madan K, Ray S, Jayagopal PB, Prabhakaran D, et al. CSI clinical practice guidelines for dyslipidemia management: executive summary. Indian Heart J. 2024 Mar;76:S6–S19.

Khalimovich MN, Erkinovna TD, Nurillo Kizi NS, Kaumovich ND. Risk factors and main aspects of lipid metabolism disturbances (literary review). J Adv Zool. 2023;44(S-6):342–346.

Park JH, Moon JH, Kim HJ, Kong MH, Oh YH. Sedentary lifestyle: overview of updated evidence of potential health risks. Korean J Fam Med. 2020 Nov;41(6):365–373. doi:10.4082/kjfm.20.0165. PMID: 33242381; PMCID: PMC7700832.

Dominguez LJ, Veronese N, Di Bella G, Cusumano C, Parisi A, Tagliaferri F, et al. Mediterranean diet in the management and prevention of obesity. Exp Gerontol. 2023 Apr 1;174:112121.

Berger JH, Chen F, Faerber JA, O’Byrne ML, Brothers JA. Adherence with lipid screening guidelines in standard and high-risk children and adolescents. Am Heart J. 2021 Feb;232:39–46. doi:10.1016/j.ahj.2020.10.058. PMID: 33229294; PMCID: PMC7854880.

Khadka B, Pandey S, Kafle D. Dyslipidemia among patients with type 2 diabetes mellitus visiting a tertiary care centre. JNMA J Nepal Med Assoc. 2023 Oct 31;61(266):758.

Haq AU, Usman K, Ullah N, Hassan T, Akhtar J, Ullah I. A cross-sectional study on prevalence and pattern of dyslipidemia and its associated factors among patients with type 2 diabetes mellitus. Pak J Med Health Sci. 2023 Mar 22;17(01):836.

Shekhawat VS, Behera V, Nayak AK, Kamal KD, Ramamoorthy A, Kumar RR, et al. Evaluation of the prevalence and pattern of dyslipidemia in newly detected type 2 diabetes mellitus patients and nondiabetic controls. J Mar Med Soc. 2024 Sep;26(3):392–397.

Mehta RK, Koirala P, Mallick RL, Parajuli S, Jha R. Dyslipidemia in patients with type 2 diabetes mellitus in a tertiary care centre: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2021 Apr 30;59(236):305.

Ahsan N, Anique M, Shafi R, Khan WU, Alam S, Noureen F. Comparing dyslipidemia patterns in newly diagnosed and long-term type 2 diabetics in a tertiary care hospital at Mirpur Khas, Sindh. Pak J Health Sci. 2024;108–113.

Haile K, Timerga A. Dyslipidemia and its associated risk factors among adult type 2 diabetic patients at Jimma University Medical Center, Southwest Ethiopia. Diabetes Metab Syndr Obes. 2020;13:4589–4597. doi:10.2147/DMSO.S283171.

Dixit AK, Dey R, Suresh A, Chaudhuri S, Panda AK, Mitra A, et al. Prevalence of dyslipidemia in patients with diabetes mellitus of an Ayurveda hospital. J Diabetes Metab Disord. 2014 May 22;13:58. doi:10.1186/2251-6581-13-58. PMID: 24918095; PMCID: PMC4051117.

D’Souza Z, Sudha. Conceptual study on Medoroga. Int Res J Pharm Med Sci. 2019;2(5):41–44.

Dhurve S. A review on Ayurvedic Nidanatmak concept of Madhumeha Vyadhi. Int J Sci Res (IJSR). 2022;11. doi:10.21275/SR22324161700.

Kawale M, Kole M. A comprehensive overview of Agni in dyslipidemia. Int J Ayurveda Pharma Res. 2023;11(Suppl 2):1–8. doi:10.47070/ijapr.v11iSuppl2.2783.

Pandey R, Bhatt N, Singhala T, Shukla V. Comparative study of Vamana and Virechana Karma in management of Sthula Pramehi with special reference to type 2 diabetes. Ayu. 2011;32:536–539. doi:10.4103/0974-8520.96129.

Suresh H, Hanmante V, Karade R. Ayurvedic management of Prameha with reference to diabetes mellitus: a case series. Natl J Res Ayurved Sci. 2022;10.

Bhaskar A, Rajpurohit A, Ekta, Rajpurohit G, Kumar P, Dudi R. Ayurvedic solutions for lifestyle-related disorders: prevention and management. Afr J Biomed Res. 2024 Dec;27(4 Suppl):911–622.

Varsakiya J, Drishya D, Kathad D. Role of Ayurvedic remedies in management of dyslipidemia: a case report. Int J AYUSH Care. 2022;6(1):1422.

Gopan Y, Kamath TS. Ayurvedic management of dyslipidemia: a conceptual analysis. Int Ayurvedic Med J [Internet]. 2024 [cited 2024 Jan]. Available from: http://www.iamj.in/posts/images/upload/237_242.pdf

Yadav U, Bhatted SK. Comparative analysis of Vamana and Shamana Chikitsa in prediabetes management: a randomized clinical trial. J Ayurveda Integr Med. 2023 Sep;14(5):100764.

Gupta V, Sharma V, Tiwari RC, Dikshit M, Singh A. Pathya Apathya: impact and role in lifestyle disorders. AYUSHDHARA. 2021;8(1):30505. doi:10.47070/ayushdhara.v8i1.637.

Chowdhury BR. World’s Best: The D.I.P. Diet. 1st ed. Faridabad (IN): Dr. Biswaroop Roy Chowdhury; 2024. p. 140.

Agnivesha. Caraka Saṃhitā, Sutrasthāna, Chapter 28, Verses 45–48. In: Shukla V, Tripathi RD, editors. Caraka Saṃhitā of Agnivesha. Vol 1. Varanasi (IN): Chaukhambha Sanskrit Pratishthan; 2014.

Kavita MB, Mallika KJ. Exploring dyslipidemia the Ayurvedic way. AYUSHDHARA. 2017;4(5):1351–1354.

Hridya A. Analysis of dyslipidemia as per Ayurveda and its management. Int J Ayurveda Pharma Res. 2022;10(10):629. doi:10.47070/ijapr.v10i10.2561.

Rekha R, Meena U, Viramgama H. Dyslipidemia: a review from Ayurveda perspective. Int J Res Anal Rev. 2023 Mar;10(1):1.

Vagbhata. Ashtanga Hridaya, Sutrasthāna, Chapter 14, Verses 20–21. In: Srikantha Murthy KR, editor and translator. Varanasi (IN): Chaukhambha Krishnadas Academy; 2012.

Agnivesha. Caraka Saṃhitā, Sutrasthāna, Chapter 20, Verses 18–19. In: Shukla V, Tripathi RD, editors. Caraka Saṃhitā of Agnivesha: Vaidyamañoramā Hindi Commentary. Vol 1. Varanasi (IN): Chaukhambha Sanskrit Pratishthan; 2014.

Agnivesha. Caraka Saṃhitā, Sutrasthāna, Chapter 28, Verse 4. In: Shukla V, Tripathi RD, editors. Caraka Saṃhitā of Agnivesha: Vaidyamañoramā Hindi Commentary. Vol 1. Varanasi (IN): Chaukhambha Sanskrit Pratishthan; 2014.

Agnivesha. Caraka Saṃhitā, Sutrasthāna, Chapter 21, Verse 21. In: Shukla V, Tripathi RD, editors. Caraka Saṃhitā of Agnivesha: Vaidyamañoramā Hindi Commentary. Vol 1. Varanasi (IN): Chaukhambha Sanskrit Pratishthan; 2014.

Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3):150–159. doi:10.1038/ncpendmet1066. PMID: 19229235.

Vagbhata. Ashtanga Hridaya [Sanskrit with English translation], Sutrasthāna, Chapter 14, Verses 20–21. In: Srikantha Murthy KR, editor and translator. 6th ed. Varanasi (IN): Chaukhambha Krishnadas Academy; 2012.

Ardisson Korat AV, Willett WC, Hu FB. Diet, lifestyle, and genetic risk factors for type 2 diabetes: a review from the Nurses’ Health Study, Nurses’ Health Study II, and Health Professionals Follow-up Study. Curr Nutr Rep. 2014 Dec;3(4):345–354. doi:10.1007/s13668-014-0103-5. PMID: 25599007; PMCID: PMC4295827.

Singh S, Nayak NR, Kande A. Conceptual study of Medo Dushti with special reference to dyslipidemia. World J Pharm Med Res. 2018;4(11):314–317.

Bhardwaj S, Bhatnagar S, Chauhan L. Implications of the concept of Viruddha Ahara in the present era. J Ayurveda Integr Med. 2024;9:b290303.

Ji A, Chaudhary G, Singh M, Sharma P. Integrating Ayurveda in chronic kidney disease management. AYUSHDHARA. 2024;11(5):257–264. doi:10.47070/ayushdhara.v11i5.1765.

Gupta A, Gupta P, Bajpai G. Tinospora cordifolia (Giloy): an insight into the multifarious pharmacological paradigms of a promising Ayurvedic medicinal herb. Heliyon. 2024 Apr;10(4):e26125. doi:10.1016/j.heliyon.2024.e26125. PMID: 38390130; PMCID: PMC10882059.

Reddy IV, Palagani N. Neem (Azadirachta indica): a review on medicinal Kalpavriksha. Int J Econ Plants. 2022;9. doi:10.23910/2/2021.0437d.

Patil PC, et al. A critical review of Karavellaka (Momordica charantia Linn.) as a Vishagna dravya (antipoisonous drug). Int Ayurvedic Med J [Internet]. 2024 [cited 2024 Mar]. Available from: http://www.iamj.in/posts/images/upload/530_534.pdf

Bhesaniya M, Sreekanth VM. Ayurvedic management of Prameha: a case study. Int J Biochem Physiol Appl Sci. 2024 Jun;13(6):2693–2701.

Srinivasan K. Fenugreek (Trigonella foenum-graecum): a review of health-beneficial physiological effects. Food Rev Int. 2006;22:203–224. doi:10.1080/87559120600586315.

Bidwai V, Bhuyan C. Healing property of Vanshlochan Churna on Dusta Vrana (non-healing ulcer): a case study. J Emerg Technol Innov Res. [Year not specified].

Sharma VP, Sharma LC. Ayurveda view on Agni: physiological consideration and biological significance. World J Pharm Med Res. 2022;8(12):210–212.

Carrasco-Gallardo C, Guzmán L, Maccioni RB. Shilajit: a natural phytocomplex with potential procognitive activity. Int J Alzheimers Dis. 2012;2012:674142. doi:10.1155/2012/674142. PMID: 22482077; PMCID: PMC3296184.

Neelayathatchi P, Neasri TM, Sanwal CS. Ayurvedic perspective and clinical significance of millets. J Ayu Int Med Sci. 2023;8(12):161–174. Available from: https://jaims.in/jaims/article/view/2962

Jeena Sikho Lifecare. Control diabetes at home: natural remedies and diet tips [Internet]. [cited 2025 May 30]. Available from: https://jeenasikho.com/control-diabetes-at-home-natural-remedies-diet-tips

Chauhan VJ, Manche V, Patrikar VG. Brahma Muhurta for healthy lifestyle: a review study. World J Pharm Res. 2019;8(6):260–265.

Shantakumari N, Sequeira S, El Deeb R. Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia. Indian Heart J. 2013 Mar–Apr;65(2):127–131. doi:10.1016/j.ihj.2013.02.010. PMID: 23647889; PMCID: PMC3861018.

Mohanty NC, Manik RK. Impact of yoga and dietary modifications on glycemic control in type 2 diabetes: an overview. Int J Futur Innov Arts Humanit Manag. 2025;4(1):1–7.

Chauhan YV, Gada JV, Misra S, Dhole CB, Palekar AV, Varthakavi PK, et al. Early dinner improves glycemic profile in habitual late eaters with uncontrolled type 2 diabetes mellitus in the short term. Cureus. 2024 May 2;16(5):e59504. doi:10.7759/cureus.59504. PMID: 38826926; PMCID: PMC11144034.

Downloads

Published

2026-01-05

How to Cite

Manish, A., Chaudhary, G., Richa, Rao, A., & Rani, T. (2026). Case Study: Ayurvedic Treatment Of Dyslipidemia Coexisting With Type 2 Diabetes Mellitus . International Research Journal of Ayurveda & Yoga, 8(6), 45-59. https://doi.org/10.48165/IRJAY.2025.80609